日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Simvastatin and Rifaximin in Decompensated Cirrhosis: A Randomized Clinical Trial

辛伐他汀和利福昔明治疗失代偿期肝硬化:一项随机临床试验

Pose, Elisa; Jiménez, César; Zaccherini, Giacomo; Campion, Daniela; Piano, Salvatore; Uschner, Frank Erhard; de Wit, Koos; Roux, Olivier; Gananandan, Kohilan; Laleman, Wim; Solé, Cristina; Alonso, Sonia; Cuyàs, Berta; Ariza, Xavier; Juanola, Adrià; Ma, Ann T; Napoleone, Laura; Gratacós-Ginès, Jordi; Tonon, Marta; Pompili, Enrico; Sánchez-Delgado, Jordi; Allegretti, Andrew S; Morales-Ruiz, Manuel; Carol, Marta; Pérez-Guasch, Martina; Fabrellas, Núria; Pich, Judit; Martell, Claudia; Joyera, María; Domenech, Gemma; Ríos, José; Torres, Ferrán; Serra-Burriel, Miquel; Hernáez, Rubén; Solà, Elsa; Graupera, Isabel; Watson, Hugh; Soriano, Germán; Bañares, Rafael; Mookerjee, Rajeshwar P; Francoz, Claire; Beuers, Ulrich; Trebicka, Jonel; Angeli, Paolo; Alessandria, Carlo; Caraceni, Paolo; Vargas, Víctor M; Abraldes, Juan G; Kamath, Patrick S; Ginès, Pere

Prospective multicentre randomised controlled trial to assess the clinical effectiveness of the novel CirrhoCare digital therapeutic management system: a study protocol

一项前瞻性多中心随机对照试验,旨在评估新型CirrhoCare数字治疗管理系统的临床疗效:研究方案

Greenham, Olivia; Gananandan, Kohilan; Balaji, Anu; Kazankov, Konstantin; Thomsen, Karen L; Bamber, Jonathan; Philip, Jenny; Wadke, Anvi; Sadique, Zia; Raja, Maruthi; Boddu, Ravan; Kumar, Ravi; Jalan, Rajiv; Mookerjee, Rajeshwar P

Systematic review and meta-analysis of biomarkers predicting decompensation in patients with compensated cirrhosis

对预测代偿期肝硬化患者失代偿的生物标志物进行系统评价和荟萃分析

Gananandan, Kohilan; Singh, Rabiah; Mehta, Gautam

Letter to the Editor: Subjective and objective burden on providers from a multicenter app-based study of patients with cirrhosis and caregivers

致编辑的信:一项基于应用程序的多中心研究探讨了肝硬化患者及其照护者在医疗服务提供者身上的主观和客观负担

Gananandan, Kohilan; Mookerjee, Rajeshwar

Fat mass: a novel digital biomarker for remote monitoring that may indicate risk for malnutrition and new complications in decompensated cirrhosis

脂肪量:一种用于远程监测的新型数字生物标志物,可能提示失代偿期肝硬化患者营养不良和新并发症的风险。

Gananandan, K; Thomas, V; Woo, W L; Boddu, R; Kumar, R; Raja, M; Balaji, A; Kazankov, K; Mookerjee, R P

Negative impact of the pandemic on hospital admissions, morbidity and early mortality for acute cirrhosis decompensation

疫情对急性肝硬化失代偿期患者的住院人数、发病率和早期死亡率的负面影响

Gananandan, Kohilan; Phillips, Alexandra; Chikhlia, Anmol; Old, Hannah; Sim, Sharmaine Jia Ying; Thakur, Niharika; Hussain, Ishrat; Kazankov, Konstantin; Mookerjee, Rajeshwar P

Natalizumab granule cell neuronopathy: FDG-PET in diagnosis and immune reconstitution with G-CSF

那他珠单抗颗粒细胞神经病:FDG-PET在诊断中的应用及G-CSF免疫重建治疗

Kamourieh, Salwa; Gananandan, Kohilan; Raffel, Joel; Nicholas, Richard